Our assaydirectlymeasureshydrogen______ levels.Whichnormotensivestrain served asour control?_____________Whichhypertensiveanimal modeldid we use?___________Follistatintreatmentreduced bloodpressure byapproximately______ mmHg.Neutralizingantibodiestargetedactivin A and______.Hypertension isdefined bysustained bloodpressure above____ mmHg.FST’santioxidanteffect is lostif it is______.What is theendogenousprotein we studiedthat antagonizesactivin?_____________Follistatin isknown toneutralizesignaling by______.Follistatinmust maintainits proper______ to befunctional.FST wasadministeredevery______ day.Which type of assayis used to evaluateNO levels in ourstudy: fluorometricor colorimetric? _____________What does theabbreviation'SHR' stand for? _____________In our study,follistatin wasadministered toSHRs over aperiod of______ weeks.The fluorescentproductproduced in theAmplexRedassay is called______.Follistatinincreases theexpression of______, which iscritical for nitricoxide production.FST lowersROS levels, asindicated by adecrease in______ levels."In our experiments,the reduction inoxidative stress wasmeasured as adecrease in the foldchange of ______.Follistatinretains itsantioxidanteffect evenwhen denatured.True/FalseEnhanced NObioavailabilityindicatesimproved______.Follistatintreatment induces______ of PVAT, aphenotypeassociated withimproved vascularfunction.Which proteinmarker indicatesa brown adiposephenotype inPVAT?_____________Our study showsthat blockingactivin signalingreduces ______production.What assay didwe use toquantifyhydrogenperoxide?_____________Our assaydirectlymeasureshydrogen______ levels.Whichnormotensivestrain served asour control?_____________Whichhypertensiveanimal modeldid we use?___________Follistatintreatmentreduced bloodpressure byapproximately______ mmHg.Neutralizingantibodiestargetedactivin A and______.Hypertension isdefined bysustained bloodpressure above____ mmHg.FST’santioxidanteffect is lostif it is______.What is theendogenousprotein we studiedthat antagonizesactivin?_____________Follistatin isknown toneutralizesignaling by______.Follistatinmust maintainits proper______ to befunctional.FST wasadministeredevery______ day.Which type of assayis used to evaluateNO levels in ourstudy: fluorometricor colorimetric? _____________What does theabbreviation'SHR' stand for? _____________In our study,follistatin wasadministered toSHRs over aperiod of______ weeks.The fluorescentproductproduced in theAmplexRedassay is called______.Follistatinincreases theexpression of______, which iscritical for nitricoxide production.FST lowersROS levels, asindicated by adecrease in______ levels."In our experiments,the reduction inoxidative stress wasmeasured as adecrease in the foldchange of ______.Follistatinretains itsantioxidanteffect evenwhen denatured.True/FalseEnhanced NObioavailabilityindicatesimproved______.Follistatintreatment induces______ of PVAT, aphenotypeassociated withimproved vascularfunction.Which proteinmarker indicatesa brown adiposephenotype inPVAT?_____________Our study showsthat blockingactivin signalingreduces ______production.What assay didwe use toquantifyhydrogenperoxide?_____________

Follistatin to the Rescue: Bingo for Lowering Pressure and Defeating ROS - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Our assay directly measures hydrogen ______ levels.
  2. Which normotensive strain served as our control? _____________
  3. Which hypertensive animal model did we use? ___________
  4. Follistatin treatment reduced blood pressure by approximately ______ mmHg.
  5. Neutralizing antibodies targeted activin A and ______.
  6. Hypertension is defined by sustained blood pressure above ____ mmHg.
  7. FST’s antioxidant effect is lost if it is ______.
  8. What is the endogenous protein we studied that antagonizes activin? _____________
  9. Follistatin is known to neutralize signaling by ______.
  10. Follistatin must maintain its proper ______ to be functional.
  11. FST was administered every ______ day.
  12. Which type of assay is used to evaluate NO levels in our study: fluorometric or colorimetric? _____________
  13. What does the abbreviation 'SHR' stand for? _____________
  14. In our study, follistatin was administered to SHRs over a period of ______ weeks.
  15. The fluorescent product produced in the AmplexRed assay is called ______.
  16. Follistatin increases the expression of ______, which is critical for nitric oxide production.
  17. FST lowers ROS levels, as indicated by a decrease in ______ levels.
  18. "In our experiments, the reduction in oxidative stress was measured as a decrease in the fold change of ______.
  19. Follistatin retains its antioxidant effect even when denatured. True/False
  20. Enhanced NO bioavailability indicates improved ______.
  21. Follistatin treatment induces ______ of PVAT, a phenotype associated with improved vascular function.
  22. Which protein marker indicates a brown adipose phenotype in PVAT? _____________
  23. Our study shows that blocking activin signaling reduces ______ production.
  24. What assay did we use to quantify hydrogen peroxide? _____________